# POC Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/poc-pharma

- Industry: Software
- Headquarters: Hong Kong, Hong Kong SAR - China
- Website: www.pharmapoc.com
- Total disclosed funding: $15M
- Latest round: Series A (Feb 4, 2022)
- Investors on record: 5

## About

Established in 2019 and based in Kowloon, Hong Kong, POC Pharma Limited develops and operates a SaaS (software-as-a-service)-based platform that provides SaaS, data and network solutions for pharma companies, distributors and wholesalers. The company is headquartered in Hong Kong, and has offices in Vietnam, Dubai and France. Its products are exported to more than 20 countries. Thomas Miklavec, the founder and CEO of the company, has 20 years of experience in Pharma field. In April 2022, it raised USD 10.3 million in series A funding led by Alven, with participation from FEBE Ventures, FJ Labs, and Picus Capital.

The company engages in the research and development of SaaS, data and network solutions for pharma companies, distributors and wholesalers. The platform provides trade programs and trade offers management, content and information sharing, data integration and visualization, customized customer engagement, multichannel commercialization, and order management.

## Funding rounds

- Series A, Feb 4, 2022, $10M — Alven, FJ Labs, Picus Capital, FEBE Ventures
- Seed, Apr 27, 2021, $4.5M — 500 Global, FJ Labs, Picus Capital, FEBE Ventures

## Investors

- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed
- FJ Labs (https://capitalatlas.ai/funds/fj-labs) — Seed, Series A
- Picus Capital (https://capitalatlas.ai/funds/picus-capital) — Seed, Series A
- FEBE Ventures (https://capitalatlas.ai/funds/febe-ventures) — Seed, Series A
- Alven (https://capitalatlas.ai/funds/alven) — Series A